Labeler
Eugia US LLC NDC Codes
Eugia US LLC lists 241 finished drug products in the FDA NDC Directory under NDC labeler code 55150.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Methotrexate, Fluorouracil, Ketamine Hydrochloride, Gentamicin, Mitomycin, Testosterone Cypionate, Diltiazem Hydrochloride, Pemetrexed, Doxercalciferol, Cyclophosphamide, Docetaxel, Phenylephrine Hydrochloride, Ketorolac Tromethamine, Neostigmine Methylsulfate, Piperacillin and Tazobactam
- Active ingredients
- Methotrexate sodium, Fluorouracil, Ketamine hydrochloride, Gentamicin sulfate, Mitomycin, Testosterone cypionate, Diltiazem hydrochloride, Pemetrexed disodium hemipentahydrate, Doxercalciferol, Cyclophosphamide, Docetaxel anhydrous, Phenylephrine hydrochloride
- NDC labeler codes
- 55150
- Strengths (from the 100 most recently listed products)
- Fluorouracil 50 mg/mL; Diltiazem hydrochloride 5 mg/mL; Docetaxel anhydrous 10 mg/mL; Phenylephrine hydrochloride 10 mg/mL; Gentamicin sulfate 40 mg/mL; Medroxyprogesterone acetate 150 mg/mL; Triamcinolone acetonide 40 mg/mL; Doxercalciferol 4 ug/2mL; Dactinomycin .5 mg/mL; Ketamine hydrochloride 100 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Milrinone lactate .2 mg/mL; Mesna 100 mg/mL; Methotrexate sodium 50 mg/2mL; Methotrexate sodium 100 mg/4mL; Methotrexate sodium 200 mg/8mL; Methotrexate sodium 250 mg/10mL; Busulfan 6 mg/mL; Testosterone enanthate 200 mg/mL; Gentamicin sulfate 10 mg/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Powder, Lyophilized, For solution, Injection, Suspension, Solution, Kit
- Routes
- Intravenous, Intramuscular, Subcutaneous, Intrathecal, Intra-articular, Soft tissue, Intralesional, Intracardiac
- Drug classes (FDA established)
- Folate Analog Metabolic Inhibitor, Nucleoside Metabolic Inhibitor, Alkylating Drug, Androgen, Aminoglycoside Antibacterial, Corticosteroid, General Anesthetic, Calcium Channel Blocker, Vitamin D2 Analog, Microtubule Inhibitor, beta-Adrenergic Agonist, alpha-1 Adrenergic Agonist, Cyclooxygenase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Azole Antifungal, Cholinesterase Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Glycopeptide Antibacterial, Platelet Aggregation Inhibitor, Progestin, beta-Adrenergic Blocker, Actinomycin, Central alpha-2 Adrenergic Agonist, Phosphodiesterase 3 Inhibitor, Cytoprotective Agent, Depolarizing Neuromuscular Blocker, Bradykinin B2 Receptor Antagonist, Hematopoietic Stem Cell Mobilizer, Estrogen Receptor Antagonist, Prostaglandin Analog, Arteriolar Vasodilator, Lipid-based Polyene Antifungal, Polyene Antifungal, Pharmacologic Cardiac Stress Test Agent, Phenothiazine, Proteasome Inhibitor, Topoisomerase Inhibitor, Lipopeptide Antibacterial, Norepinephrine Releasing Agent, alpha-Adrenergic Agonist, Dihydropyridine Calcium Channel Blocker, Opioid Antagonist, Substance P/Neurokinin-1 Receptor Antagonist, Nondepolarizing Neuromuscular Blocker, Atypical Antipsychotic
- HCPCS / J-code
- J1040 — Injection, methylprednisolone acetate, 80 mg, J1050 — Injection, medroxyprogesterone acetate, 1 mg, J0131 — Injection, acetaminophen, 10 mg
- Package NDCs
- 115 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Carboplatin | Carboplatin 600 mg/60mL | Injection, SolutionIntravenous | 55150-386 | 55150-0386-00 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 55150-318 | 55150-0318-25 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 55150-319 | 55150-0319-25 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 55150-342 | 55150-0342-0155150-0342-0555150-0342-25 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 55150-343 | 55150-0343-0155150-0343-0555150-0343-25 | — |
| Dexamethasone Sodium Phosphate | Dexamethasone sodium phosphate 10 mg/mL | InjectionIntramuscular, Intravenous | 55150-304 | 55150-0304-25 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | InjectionIntravenous | 55150-286 | 55150-0286-10 | — |
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 55150-352 | 55150-0352-01 | — |
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 55150-353 | 55150-0353-01 | — |
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 55150-354 | 55150-0354-01 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride .4 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 55150-328 | 55150-0328-1055150-0328-25 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride .4 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 55150-327 | 55150-0327-1055150-0327-25 | — |
| Tigecycline | Tigecycline 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 55150-228 | 55150-0228-10 | — |
| Dexamethasone Sodium Phosphate | Dexamethasone sodium phosphate 100 mg/10mL | InjectionIntramuscular, Intravenous | 55150-305 | 55150-0305-10 | — |
| Hydroxyprogesterone Caproate | Hydroxyprogesterone caproate 1250 mg/5mL | InjectionIntramuscular | 55150-311 | 55150-0311-0155150-0311-05 | — |
| Furosemide | Furosemide 20 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 55150-322 | 55150-0322-25 | — |
| Furosemide | Furosemide 40 mg/4mL | Injection, SolutionIntramuscular, Intravenous | 55150-323 | 55150-0323-25 | — |
| Furosemide | Furosemide 100 mg/10mL | Injection, SolutionIntramuscular, Intravenous | 55150-324 | 55150-0324-25 | — |
| Vecuronium Bromide | Vecuronium bromide 10 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 55150-235 | 55150-0235-11 | — |
| Vecuronium Bromide | Vecuronium bromide 20 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 55150-236 | 55150-0236-20 | — |
| Progesterone | Progesterone 50 mg/mL | Injection, SolutionIntramuscular | 55150-306 | 55150-0306-10 | — |
| Argatroban | Argatroban 50 mg/50mL | Injection, SolutionIntravenous | 55150-241 | 55150-0241-0155150-0241-10 | — |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | 55150-186 | 55150-0186-05 | — |
| Paricalcitol | Paricalcitol 2 ug/mL | InjectionIntravenous | 55150-212 | 55150-0212-01 | — |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | 55150-213 | 55150-0213-01 | — |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | 55150-214 | 55150-0214-02 | — |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | 55150-215 | 55150-0215-02 | — |
| Bivalirudin | Bivalirudin 250 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 55150-210 | 55150-0210-10 | — |
| Ertapenem | Ertapenem sodium 1 g/1 | InjectionIntramuscular, Intravenous | 55150-282 | 55150-0282-20 | — |
| Fondaparinux Sodium | Fondaparinux sodium 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 55150-230 | 55150-0230-0255150-0230-10 | — |
| Fondaparinux Sodium | Fondaparinux sodium 5 mg/.4mL | Injection, SolutionSubcutaneous | 55150-231 | 55150-0231-0255150-0231-10 | — |
| Fondaparinux Sodium | Fondaparinux sodium 7.5 mg/.6mL | Injection, SolutionSubcutaneous | 55150-232 | 55150-0232-0255150-0232-10 | — |
| Fondaparinux Sodium | Fondaparinux sodium 10 mg/.8mL | Injection, SolutionSubcutaneous | 55150-233 | 55150-0233-0255150-0233-10 | — |
| Zoledronic Acid | Zoledronic acid 5 mg/100mL | Injection, SolutionIntravenous | 55150-283 | 55150-0283-99 | — |
| Adenosine | Adenosine 60 mg/20mL | Injection, SolutionIntravenous | 55150-192 | 55150-0192-0155150-0192-20 | — |
| Adenosine | Adenosine 90 mg/30mL | Injection, SolutionIntravenous | 55150-193 | 55150-0193-0155150-0193-30 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-251 | 55150-0251-24 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-252 | 55150-0252-20 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-253 | 55150-0253-50 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-254 | 55150-0254-24 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-255 | 55150-0255-20 | — |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionInfiltration, Perineural | 55150-256 | 55150-0256-50 | — |
| Fluphenazine Decanoate | Fluphenazine decanoate 125 mg/5mL | Injection, SolutionIntramuscular, Subcutaneous | 55150-267 | 55150-0267-05 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 55150-331 | 55150-0331-01 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 55150-332 | 55150-0332-01 | — |
| Rocuronium Bromide | Rocuronium bromide 50 mg/5mL | Injection, SolutionIntravenous | 55150-225 | 55150-0225-05 | — |
| Rocuronium Bromide | Rocuronium bromide 100 mg/10mL | Injection, SolutionIntravenous | 55150-226 | 55150-0226-10 | — |
| Meropenem | Meropenem 500 mg/1 | Injection, Powder, For solutionIntravenous | 55150-207 | 55150-0207-20 | — |
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | 55150-208 | 55150-0208-30 | — |
| Etomidate | Etomidate 20 mg/10mL | Injection, SolutionIntravenous | 55150-221 | 55150-0221-10 | — |
Eugia US LLC: common questions
- What is Eugia US LLC's NDC labeler code?
- 55150. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Eugia US LLC?
- Med-Code's HCPCS directory matches J1040, J1050, J0131 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.